“…In addition to the need for localized delivery of antibiotics [20,21], the ideal delivery biomaterial for uses as a prophylactic against CEID infection should be: 1) easy to apply at the time of CIED implantation; 2) an enhancer of tissue pocket healing, which could reduce seroma formation and further reduce the likelihood of infection; 3) completely biodegradable so that it would not be a source for further inflammation, biofilm formation, or interfere with subsequent surgical intervention; 4) cost-effective to enable it to become a standard of care; and 5) help mitigate cytotoxicity of delivered drugs. While clinically available products address many of these requirements [6,7,22,23], they do not enhance healing, require additional attention to implant technique, are relatively expensive to manufacture, and do not possess anti-cytotoxic actions.…”